本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ovid Therapeutics Inc.

2.66
-0.0400-1.48%
成交量:16.44萬
成交額:44.05萬
市值:5.19億
市盈率:-10.49
高:2.72
開:2.68
低:2.66
收:2.70
52周最高:3.11
52周最低:1.12
股本:1.95億
流通股本:1.63億
量比:2.64
換手率:0.10%
股息:- -
股息率:- -
每股收益(TTM):-0.2535
每股收益(LYR):-0.2325
淨資產收益率:-25.96%
總資產收益率:-23.46%
市淨率:2.47
市盈率(LYR):-11.44

資料載入中...

2023/04/27

重要事件披露

8-K - Current report
2023/03/13

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/13

重要事件披露

8-K - Current report
2023/03/10

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report
2022/11/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/09

重要事件披露

8-K - Current report
2022/08/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/10

重要事件披露

8-K - Current report
2022/05/11

重要事件披露

8-K - Current report
2022/05/10

重要事件披露

8-K - Current report
2022/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]